Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban in ECMO
NCT05226442Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2021
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of argatroban in thrombosis, sponsored by Medical University of Vienna. Started Dec 2021; status: completed.
02
Drugs
argatroban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT05226442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05226442.